Obiettivo
Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the level of product knowledge, production technology and quality management in those days. Current production techniques are optimised, in-process control is implemented and tight quality management systems are in place. These developments have brought testing for lot-to-lot consistency into reach. The consistency approach involves the use of a set of parameters obtained by using innovative in vitro technologies, to define the product along the manufacturing pathway and to ensure similarity to a lot of proven efficacy and safety.
The ambition of the VAC2VAC project is a demonstrated proof of concept of the consistency approach for lot release testing. We will develop/optimise and validate innovative in vitro methods for the categories of established vaccines on the market. Product profiles will be defined using analytical methods, cell-based assays and bioinformatics.
The project includes 7 WPs: 4 on R&D, and one each on validation, promotion to regulatory acceptance and consortium management. Consortium partners represent the vaccine stakeholder groups (OMCLs, Academia, Translational research institutes and Vaccinology alliances) and are complementary for the expertise ranging from method development and validation to facilitating and providing guidance to regulatory acceptance. Acceptance will be promoted by strategic guidance activities: a roadmap conference, workshops and training courses. Implementation of the consistency approach in lot release testing has multiple impact: 1) strengthening fundamental understanding of vaccine products resulting in enhanced understanding of vaccine quality 2) strengthening competitiveness of European Vaccine Industries resulting in
reduced QC costs and shortened QC time. 3) strengthening European animal welfare policies resulting in a substantial reduction in animal numbers for vaccine QC
Campo scientifico
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP.
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP.
- natural sciencesphysical sciencesopticsspectroscopyemission spectroscopy
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- natural scienceschemical sciencesanalytical chemistrymass spectrometry
Parole chiave
Programma(i)
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
69115 Heidelberg
Germania
Mostra sulla mappa
Partecipanti (24)
3721 MA Bilthoven
Mostra sulla mappa
LS2 7UE Leeds
Mostra sulla mappa
63225 Langen
Mostra sulla mappa
1049 Bruxelles / Brussel
Mostra sulla mappa
3584 CS Utrecht
Mostra sulla mappa
9713 GZ Groningen
Mostra sulla mappa
Partecipazione conclusa
2500 EJ Den Haag
Mostra sulla mappa
3584 CH Utrecht
Mostra sulla mappa
00161 Roma
Mostra sulla mappa
1220 Wien
Mostra sulla mappa
69393 Lyon
Mostra sulla mappa
1050 Elsene
Mostra sulla mappa
2288 GJ Rijswijk Zh
Mostra sulla mappa
69007 Lyon
Mostra sulla mappa
1348 Louvain La Neuve
Mostra sulla mappa
69007 Lyon
Mostra sulla mappa
55218 Ingelheim
Mostra sulla mappa
5831 AN Boxmeer
Mostra sulla mappa
1330 Rixensart
Mostra sulla mappa
3531AH Utrecht
Mostra sulla mappa
Partecipazione conclusa
2304 Orth An Der Donau
Mostra sulla mappa
CT13 9NJ Sandwich
Mostra sulla mappa
3490 Kvistgard
Mostra sulla mappa
3721 MA Bilthoven
Mostra sulla mappa